Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies

Tumor genetic testing is standard of care for patients with advanced lung adenocarcinoma but the fraction of patients who derive clinical benefit remains undefined. Here, we report the experience of 860 patients with metastatic lung adenocarcinoma analyzed prospectively for mutations in >300 canc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Discov
Main Authors: Jordan, Emmet J., Kim, Hyunjae R., Arcila, Maria E., Barron, David, Chakravarty, Debyani, Gao, JianJiong, Chang, Matthew T., Ni, Andy, Kundra, Ritika, Jonsson, Philip, Jayakumaran, Gowtham, Gao, Sizhi Paul, Johnsen, Hannah C., Hanrahan, Aphrothiti J., Zehir, Ahmet, Rekhtman, Natasha, Ginsberg, Michelle S., Li, Bob T., Yu, Helena A., Paik, Paul K., Drilon, Alexander, Hellmann, Matthew D., Reales, Dalicia N., Benayed, Ryma, Rusch, Valerie W., Kris, Mark G., Chaft, Jamie E., Baselga, Jose, Taylor, Barry S., Schultz, Nikolaus, Rudin, Charles M., Hyman, David M., Berger, Michael F., Solit, David B., Ladanyi, Marc, Riely, Gregory J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482929/
https://ncbi.nlm.nih.gov/pubmed/28336552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-16-1337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados